Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Surya P Ayalasomayajula

A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications

scientific article published on March 2002

A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects

scientific article published on 29 January 2008

Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

scientific article

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

scientific article

Drug efflux pumps: challenges and opportunities. 14-18 November 1999, New Orleans, LA, USA.

scientific article

Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin

scientific article published on 01 May 2007

Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects

scientific article published on 19 May 2008

Evaluation of food effect on the oral bioavailability of pradigastat, a diacylglycerol acyltransferase 1 inhibitor

scientific article published on 11 May 2015

Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension

scientific article published on 17 September 2010

Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects

scientific article published on December 2007

Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).

scientific article published on April 2009

Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells

scientific article published on August 2002

Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas

scientific article published in September 2004

Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model

scientific article

Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells

scientific article published on September 2003

Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats

scientific article published on 01 February 1999

Pharmacokinetics After Single Ascending Dose, Food Effect, and Safety of Sacubitril/Valsartan (LCZ696), an Angiotensin Receptor and Neprilysin Inhibitor, in Healthy Japanese Subjects

scientific article

Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor

scientific article published on 15 September 2009

Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration

scientific article published in October 2004

Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

scientific article published in March 2006

Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression

scientific article published on March 2003

Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model

scientific article published in March 2005

Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor

scientific article published on March 2004

The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects

scientific article published on 12 December 2015

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

scientific article